Elevated expression of E-cadherin in primary breast cancer and its corresponding metastatic lymph node

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 7, 2015, Pages 11752-11758

  Chen, Lin ^a   Jian, Wei ^b   Lu, Leisheng ^b   Zheng, Lijun ^b   Yu, Zhen ^b   Zhou, Donglei ^b  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

E cadherin; Metastatic lymph node; Primary breast cancer; Real time PCR

Indexed keywords

UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CLINICAL ARTICLE; FEMALE; GENE DOSAGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIMARY TUMOR; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

EID: 84940707577     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ansquer Y, Mandelbrot L, Lehy T, Salomon L, Dhainaut C, Madelenat P, Feldmann G and Walker F. Expression of BRCA1, HER-1 (EGFR) and HER-2 in sporadic breast cancer and relationships to other clinicopathological prognostic features. Anticancer Res 2005; 25: 4535-4541.
2. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N and Niitsu Y. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 1995; 15: 1175-1181.
3. Wijnhoven BP, Dinjens WN and Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000; 87: 992-1005.
4. Thoreson MA, Anastasiadis PZ, Daniel JM, Ireton RC, Wheelock MJ, Johnson KR, Hummingbird DK and Reynolds AB. Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol 2000; 148: 189-202.
5. Taraszka KS, Higgins JM, Tan K, Mandelbrot DA, Wang JH and Brenner MB. Molecular basis for leukocyte integrin alpha(E)beta(7) adhesion to epithelial (E)-cadherin. J Exp Med 2000; 191: 1555-1567.
6. Lickert H, Bauer A, Kemler R and Stappert J. Casein kinase II phosphorylation of E-cadherin increases E-cadherin/beta-catenin interaction and strengthens cell-cell adhesion. J Biol Chem 2000; 275: 5090-5095.
7. Kowalski PJ, Rubin MA and Kleer CG. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 2003; 5: R217-222.
8. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M and Cano A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993; 142: 987-993.
9. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W. E-cadherin-mediated cell-cell adhesion pre vents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-185.
10. Lipponen P, Saarelainen E, Ji H, Aaltomaa S and Syrjanen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994; 174: 101-109.
11. Moll R, Mitze M, Frixen UH and Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993; 143: 1731-1742.
12. Bukholm IK, Nesland JM and Borresen-Dale AL. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. J Pathol 2000; 190: 15-19.
13. Hunt NC, Douglas-Jones AG, Jasani B, Morgan JM and Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch 1997; 430: 285-289.
14. Lay MJ and Wittwer CT. Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin Chem 1997; 43: 2262-2267.
15. Kreuzer G and Boquoi E. [Significance of fine needle biopsy in the diagnosis of breast cancer. 1: Indications, methodology and malignancy criteria of puncture cytology]. Fortschr Med 1985; 103: 381-384.
16. Gaiser T and Bernhards J. Tyramide signal amplification: an enhanced method for immunohistochemistry on methyl-methacrylate-embedded bone marrow trephine sections. Acta Haematol 2007; 117: 122-127.
17. Chomczynski P and Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 2006; 1: 581-585.
18. Harigopal M, Berger AJ, Camp RL, Rimm DL and Kluger HM. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer. Clin Cancer Res 2005; 11: 4083-4089.
19. Gupta A, Deshpande CG and Badve S. Role of E-cadherins in development of lymphatic tumor emboli. Cancer 2003; 97: 2341-2347.
20. Park D, Karesen R, Axcrona U, Noren T and Sauer T. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. Apmis 2007; 115: 52-65.
21. Rashid MG, Sanda MG, Vallorosi CJ, Rios-Doria J, Rubin MA and Day ML. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. Cancer Res 2001; 61: 489-492.
22. Liang Y, McDonnell S and Clynes M. Examining the relationship between cancer invasion/metastasis and drug resistance. Curr Cancer Drug Targets 2002; 2: 257-277.
23. Cleton-Jansen AM. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res 2002; 4: 5-8.
24. Yoshida R, Kimura N, Harada Y and Ohuchi N. The loss of E-cadherin, alpha-and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int J Oncol 2001; 18: 513-520.
25. De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ and Cleton-Jansen AM. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997; 183: 404-411.
26. Ji X, Woodard AS, Rimm DL and Fearon ER. Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ 1997; 8: 773-778.
27. Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, Morales S, Giordano C, Bartella V, Casaburi I and Ando S. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res 2007; 67: 3412-3421.
28. Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE and Graff JR. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res 2000; 60: 4346-4348.